First in-human procedure completed using the simplified laparoscopic system

December 06, 2022 11:06 AM Eastern Standard Time

BOSTON--(BUSINESS WIRE)--New View Surgical, an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), announced today the first-in-human procedure utilizing the VisionPort™ System. The VisionPort System was used to complete a laparoscopic cholecystectomy for removal of a gall bladder and was performed at Lowell General Hospital in Lowell, Massachusetts by Dr. David Earle, founder of the New England Hernia Center and associate professor at Tufts University School of Medicine in Boston.

“The VisionPort system is a revolutionary product for laparoscopy that addresses many unmet needs in the operating room,” shared Dr. Earle. “I believe that the VisionPort will not only change how surgeons think about performing minimally invasive surgery but will enhance laparoscopy in both academic and austere environments. This is the first major innovation in visualization since laparoscopy first gained popularity in the early 1990s, and I’m very excited to be a part of it.”

The VisionPort System is a novel surgical imaging and access system that eliminates the need for a surgical team member to hold and manage a laparoscope and eliminates the need for a separate port in the patient. The innovative single-use VisionPort places the camera on the distal end of an access port allowing multiple advantages over existing laparoscopic systems. By combining 6 pieces of equipment needed for traditional laparoscopic surgery into two, it provides value across multiple stakeholders. The VisionPort System received FDA 510(k) clearance in June 2021.

“The New View Surgical team is excited to embark on this next step in our journey,” stated Bryce Klontz, New View Surgical President and CEO. “We are fortunate to have thought leaders like Dr. Earle partnering with us during the initial limited market release of the VisionPort System. With each additional procedure we are collecting robust clinical and economic data in support of our value proposition and learning from our partner surgeons as we refine our strategy for full commercial release in 2023.”

About New View Surgical, Inc

New View Surgical is an emerging medical device company focused on the development and commercialization of the VisionPort System, a novel surgical imaging and access system for minimally invasive surgery. The company is led by an experienced team of medical device innovators and commercial experts who have come together to design and commercialize impactful solutions that address a variety of unmet market needs The company’s proprietary VisionPort System combines multiple imaging and access devices into one simple, easy-to-use device that is disposable and is expected to bring a variety of clinical, operational, and financial advantages to minimally invasive surgery operating rooms around the world. For more information, please visit www.newviewsurg.com.

Contacts For Press Inquiries:

New View Surgical, Inc.
info@newviewsurg.com
www.newviewsurg.com